Literature DB >> 11852167

Crossing international boundaries: implications for the Term Breech Trial Data Coordinating Centre.

Sheila A Hewson1, Julie Weston, Mary E Hannah.   

Abstract

The Term Breech Trial (TBT) is a multicenter, international randomized trial that compared a policy of planned cesarean section with a policy of planned vaginal birth for selected pregnancies with a fetus in breech presentation at term. The TBT involved 121 centers in 26 countries that recruited 2088 women between January 9, 1997 and April 21, 2000. This paper briefly describes the impact of broad international collaboration on data coordinating center activities, including center selection, obtaining ethics approvals, data management, center funding, and recruitment.

Entities:  

Mesh:

Year:  2002        PMID: 11852167     DOI: 10.1016/s0197-2456(01)00190-8

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  3 in total

1.  The costs of planned cesarean versus planned vaginal birth in the Term Breech Trial.

Authors:  Roberto Palencia; Amiram Gafni; Mary E Hannah; Susan Ross; Andrew R Willan; Sheila Hewson; Darren McKay; Walter Hannah; Hilary Whyte; Kofi Amankwah; Mary Cheng; Patricia Guselle; Michael Helewa; Ellen D Hodnett; Eileen K Hutton; Rose Kung; Saroj Saigal
Journal:  CMAJ       Date:  2006-04-11       Impact factor: 8.262

2.  Designing and implementing sample and data collection for an international genetics study: the Type 1 Diabetes Genetics Consortium (T1DGC).

Authors:  Joan E Hilner; Letitia H Perdue; Elizabeth G Sides; June J Pierce; Ana M Wägner; Alan Aldrich; Amanda Loth; Lotte Albret; Lynne E Wagenknecht; Concepcion Nierras; Beena Akolkar
Journal:  Clin Trials       Date:  2010-07-05       Impact factor: 2.486

3.  Quality control of phenotypic forms data in the Type 1 Diabetes Genetics Consortium.

Authors:  Letitia H Perdue; Lotte Albret; Alan Aldrich; Amanda Loth; Elizabeth G Sides; Angela Dove; Ana M Wägner; Rebecca Waterman; June J Pierce; Beena Akolkar; Michael W Steffes; Joan E Hilner
Journal:  Clin Trials       Date:  2010-07-05       Impact factor: 2.486

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.